Daiwa Securities Group Inc. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 33 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5
-28.6%
2,7280.0%0.00%
Q2 2023$7
+40.0%
2,7280.0%0.00%
Q1 2023$5
+66.7%
2,728
+236.8%
0.00%
Q4 2022$3810
+142.5%
0.00%
Q3 2022$03340.0%0.00%
Q2 2022$0
-100.0%
3340.0%0.00%
Q1 2022$1,0000.0%3340.0%0.00%
Q4 2021$1,000
-50.0%
3340.0%0.00%
Q3 2021$2,000
+100.0%
334
+115.5%
0.00%
Q2 2021$1,0000.0%1550.0%0.00%
Q1 2021$1,0000.0%1550.0%0.00%
Q4 2020$1,0001550.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders